Abstract
Targeting of MMP-9 could be a useful approach for anticancer therapy. The inhibitory activities of 23 flavonoids on tumor necrosis factors alpha (TNF)-induced matrix metalloproteinases 9 (MMP-9) gene expression were analyzed quantitatively. To elucidate the relationships between the structural properties of flavonoids and their inhibitory activities, comparative molecular field analysis and comparative molecular similarity indices analysis were carried out. The structural conditions required for high inhibitory activity towards TNF-induced MMP-9 gene expression were derived. In addition, for spiraeoside, which showed the best activity among the test compounds, reverse transcription polymerase chain reaction (PCR), real-time PCR analysis, and promoter-reporter assay were performed. Spiraeoside could be a lead compound for the anticancer agents.
Keywords: Matrix metallopeptidase 9, CoMFA, CoMSIA, flavonoid, spiraeoside.
Letters in Drug Design & Discovery
Title:Relationships Between the Structural Properties of Flavonoids and their Inhibitory Activities Against Matrix Metallopeptidase 9
Volume: 14 Issue: 1
Author(s): Soon Young Shin, Hyeryoung Jung, Yearam Jung, Beom Soo Kim, Young Han Lee and Yoongho Lim
Affiliation:
Keywords: Matrix metallopeptidase 9, CoMFA, CoMSIA, flavonoid, spiraeoside.
Abstract: Targeting of MMP-9 could be a useful approach for anticancer therapy. The inhibitory activities of 23 flavonoids on tumor necrosis factors alpha (TNF)-induced matrix metalloproteinases 9 (MMP-9) gene expression were analyzed quantitatively. To elucidate the relationships between the structural properties of flavonoids and their inhibitory activities, comparative molecular field analysis and comparative molecular similarity indices analysis were carried out. The structural conditions required for high inhibitory activity towards TNF-induced MMP-9 gene expression were derived. In addition, for spiraeoside, which showed the best activity among the test compounds, reverse transcription polymerase chain reaction (PCR), real-time PCR analysis, and promoter-reporter assay were performed. Spiraeoside could be a lead compound for the anticancer agents.
Export Options
About this article
Cite this article as:
Shin Young Soon, Jung Hyeryoung, Jung Yearam, Kim Soo Beom, Lee Han Young and Lim Yoongho, Relationships Between the Structural Properties of Flavonoids and their Inhibitory Activities Against Matrix Metallopeptidase 9, Letters in Drug Design & Discovery 2017; 14 (1) . https://dx.doi.org/10.2174/1570180813666160919161434
DOI https://dx.doi.org/10.2174/1570180813666160919161434 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting the SUMO E2 Conjugating Enzyme Ubc9 Interaction for Anti-Cancer Drug Design
Anti-Cancer Agents in Medicinal Chemistry Neuropeptides as Therapeutic Targets in Anxiety Disorders
Current Pharmaceutical Design Recent Development and Future Prospects of Molecular Targeted Therapy in Prostate Cancer
Current Molecular Pharmacology Peptide Targeted Copper-64 Radiopharmaceuticals
Current Topics in Medicinal Chemistry The ABCA2 Transporter: Intracellular Roles in Trafficking and Metabolism of LDL-Derived Cholesterol and Sterol-Related Compounds
Current Drug Metabolism Natural Products Derived from Traditional Chinese Medicine as Novel Inhibitors of the Epidermal Growth Factor Receptor
Combinatorial Chemistry & High Throughput Screening The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis
Current Cancer Drug Targets Cancer Stem Cells and Colorectal Cancer: An Overview
Current Topics in Medicinal Chemistry PET Imaging for Gene & Cell Therapy
Current Gene Therapy Epigenome-Wide Association Studies (EWAS) in Cancer
Current Genomics Strategies for the Assessment of Metabolic Profiles of Steroid Hormones in View of Diagnostics and Drug Monitoring: Analytical Problems and Challenges
Current Drug Metabolism Inhibition of Fatty Acid Synthase by Polyphenols
Current Medicinal Chemistry Patent Selections:
Recent Patents on Biomarkers Current Evaluation of the Millennium Phytomedicine- Ginseng (II): Collected Chemical Entities, Modern Pharmacology, and Clinical Applications Emanated from Traditional Chinese Medicine
Current Medicinal Chemistry Chip-Based High Throughput Screening of Herbal Medicines
Combinatorial Chemistry & High Throughput Screening Thirty Years of Polyamine-Related Approaches to Cancer Therapy. Retrospect and Prospect. Part 1. Selective Enzyme Inhibitors
Current Drug Targets An Overview on Different Classes of Viral Entry and Respiratory Syncitial Virus (RSV) Fusion Inhibitors
Current Medicinal Chemistry Brachytherapy: State of the Art and Possible Improvements
Anti-Cancer Agents in Medicinal Chemistry Clinical Use of Therapies Targeting Tumor Vasculature and Stroma
Current Cancer Drug Targets Regulation of MET Receptor Signaling by SOCS1 and its Implications for Hepatocellular Carcinoma
Current Pharmaceutical Design